# Projects

| Project | Status | Notes |
|---------|--------|-------|
| ADRIATIC Follow-up Assays | Active | Durvalumab + tremelimumab combination endpoints |
| Biomarker Reproducibility Study | Active | Comparing 2017-2019 vs 2020-2024 protocol results |
| AI Screening Replacement Assessment | Planning | Need clear validation framework before starting |
| CRISPR Screen Analysis Pipeline | Backlog | Manual analysis taking too long |
